One previous study also suggested that the pharmacological inhibition of USP8 can induce ferroptosis and inhibit the progression of hepatocellular carcinoma by decreasing the stability of the O-GlcNAcylation of solute carrier family 7 member 11 (SLC7A11) [18]. Here, SLC7A11 is linked to hepatocellular carcinoma.